A substantial transmission bottleneck among newly and recently HIV-1-infected injection drug users in st petersburg, Russia

Journal of Infectious Diseases

Volumn 201, Issue 11, 2010, Pages 1697-1702

  Masharsky, Alexey E ^a,b   Dukhovlinova, Elena N ^a   Verevochkin, Sergei V ^a,b   Toussova, Olga V ^a   Skochilov, Roman V ^a   Anderson, Jeffrey A ^d,e   Hoffman, Irving ^d,e   Cohen, Myron S ^d,e   Swanstrom, Ronald ^d,e   Kozlov, Andrei P ^a,c  

^a Biomedical Center   (Russian Federation)

^b Institute for Highly Pure Biopreparations   (Russian Federation)

^c ST PETERSBURG STATE UNIVERSITY   (Russian Federation)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN;

ARTICLE; BLOOD SAMPLING; DRUG USE; GENE AMPLIFICATION; GENETIC VARIABILITY; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RUSSIAN FEDERATION; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 77951898043     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652702     Document Type: Article

References (16)

1. Keele BF, Giorgi EE, Salazar-Gonzalez JF, et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 2008 105:7552-7557.
2. Haaland RE, Hawkins PA, Salazar-Gonzalez J, et al. Inflammatory gen- ital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog 2009 5;e1000274.
3. Abrahams MR, Anderson JA, Giorgi EE, et al. Quantitating the multiplicity of infection with human immunodeficiency virus type 1 subtype C reveals a non-Poisson distribution of transmitted variants. J Virol 2009 83:3556-3567.
4. Sagar M, Lavreys L, Baeten JM, et al. Identification of modifiable factors that affect the genetic diversity of the transmitted HIV-1 population. AIDS 2004 18:615-619.
5. Sagar M, Kirkegaard E, Long EM, et al. Human immunodeficiency virus type 1 (HIV-1) diversity at time of infection is not restricted to certain risk groups or specific HIV-1 subtypes. J Virol 2004 78:7279-7283.
6. Greenier JL, Miller CJ, Lu D, et al. Route of simian immunodeficiency virus inoculation determines the complexity but not the identity of viral variant populations that infect rhesus macaques. J Virol 2001 75: 3753-3765.
7. Keele BF, Hui L, Learn GH, et al. Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. J Exp Med 2009 206:1117-1134.
8. Rybarczyk BJ, Montefiori D, Johnson PR, et al. Correlation between env V1/V2 region diversification and neutralizing antibodies during primary infection by simian immunodeficiency virus sm in rhesus macaques. J Virol 2004 78:3561-3571.
9. Beyrer C, Baral S, Shaboltas A, et al. The feasibility of HIV vaccine efficacy trials among Russian injection drug users. Vaccine 2007 25:7014-7016.
10. Shaboltas AV, Toussova OV, Hoffman IF, et al. HIV prevalence, sociodemographic, and behavioral correlates and recruitment methods among injection drug users in St. Petersburg, Russia. J Acquir Immune Defic Syndr 2006 41:657-663.
11. Kozlov AP, Shaboltas AV, Toussova OV, et al. HIV incidence and factors associated with HIV acquisition among injection drug users in St. Petersburg, Russia. AIDS 2006 20:901-906.
12. Fiebig EW, Wright DJ, Rawal BD, et al. Dynamics of HIV viremia and antibody seroconversion in plasma donors: implications for diagnosis and staging of primary HIV infection. AIDS 2003 17:1871-1879.
13. Abdala N, Krasnoselskikh TV, Durante AJ, et al. Sexually transmitted infections, sexual risk behaviors and the risk of heterosexual spread of HIV among and beyond IDUs in St. Petersburg, Russia. Eur Addict Res 2008 14:19-25.
14. Bobkov AF, Kazennova EV, Selimova LM, et al. Temporal trends in the HIV-1 epidemic in Russia: predominance of subtype A. J Med Virol 2004 74:191-196.
15. Learn GH, Muthui D, Brodie SJ, et al. Virus population homogenization following acute human immunodeficiency virus type 1 infection. J Virol 2002 76:11953-11959.
16. Bar KJ, Li H, Chamberland A, et al. Wide variation in the multiplicity of HIV-1 infection among injection drug users. J Virol (in press).